Acadia Pharmaceuticals Inc (ACAD) Com Stk USD0.0001

Sell:$16.55Buy:$16.58$0.30 (1.85%)

NASDAQ:0.84%
Prices delayed by at least 15 minutes
Sell:$16.55
Buy:$16.58
Change:$0.30 (1.85%)
Prices delayed by at least 15 minutes
Sell:$16.55
Buy:$16.58
Change:$0.30 (1.85%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
19 August 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
31,747$15.28$485,094.16186,555
19 August 2024
Brendan TeehanCOO
Sell
Tax related
9,534$15.28$145,679.5252,177
19 August 2024
Mark C SchneyerCFO
Sell
Tax related
9,733$15.28$148,720.2443,735
10 June 2024
Mark C SchneyerCFO
Sell
Tax related
975$14.79$14,420.2534,564
2 May 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
11,427$16.94$193,573.38155,231
2 May 2024
Brendan TeehanCOO
Sell
Tax related
3,477$16.94$58,900.3842,133
2 May 2024
Mark C SchneyerCFO
Sell
Tax related
3,503$16.94$59,340.8232,053
2 May 2024
James K. (Jim) KiharaChief Accounting Officer
Sell
Tax related
1,326$16.94$22,462.4414,370
8 April 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
8,858$17.87$158,292.46161,983
8 April 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
17,716$17.87$316,584.92144,267

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 October 2023
Stephen R. DavisPresident/CEO
Sell
Tax related
51,563$21.96$1,132,323.4889,131
19 August 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
31,747$15.28$485,094.16186,555
6 October 2023
Austin D KimCompany Secretary
Sell
Tax related
16,369$21.96$359,463.2445,857
27 March 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
17,714$17.90$317,080.60118,842
8 April 2024
Stephen R. DavisPresident/CEO
Sell
Tax related
17,716$17.87$316,584.92144,267

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.